Reciprocal interaction between intestinal microbiota and mucosal lymphocyte in cynomolgus monkeys after alemtuzumab treatment

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 899-910

  Li, Q R ^a   Wang, C Y ^a   Tang, C ^a   He, Q ^a   Li, N ^a   Li, J S ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Alemtuzumab; denaturing gradient gel electrophoresis; DNA sequencing, intestinal microbiota; lymphocyte depletion

Indexed keywords

ALEMTUZUMAB; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANIMAL EXPERIMENT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYNOMOLGUS MONKEY; ESCHERICHIA COLI; FAECALIBACTERIUM PRAUSNITZII; HAPLORHINI; INTESTINE FLORA; INTESTINE MUCOSA; LYMPHOCYTE; LYMPHOCYTE DEPLETION; MALE; MICROBIAL COMMUNITY; NONHUMAN; ORGAN TRANSPLANTATION; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; SHIGELLA FLEXNERI; TREATMENT DURATION;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BACTERIA; ELECTROPHORESIS; FLOW CYTOMETRY; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; LYMPHOCYTES; MACACA FASCICULARIS; MALE; MICROBIOTA; PHYLOGENY; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

EID: 84875721290     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12148     Document Type: Article

References (41)

1. Hale G, Dyer MJ, Clark MR, et al. Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H. Lancet 1988; 2: 1394-1399. (Pubitemid 19004485)
2. Flynn JM, Byrd JC,. Campath-1H monoclonal antibody therapy. Curr Opin Oncol 2000; 12: 574-581. (Pubitemid 32039657)
3. Ciancio G, Burke GW, Gaynor JJ, et al. A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up. Clin Transplant 2008; 22: 200-210. (Pubitemid 351420014)
4. Margreiter R, Klempnauer J, Neuhaus P, et al. Alemtuzumab (Campath-1H) and tacrolimus monotherapy after renal transplantation: Results of a prospective randomized trial. Am J Transplant 2008; 8: 1480-1485. (Pubitemid 351989498)
5. Calne R, Moffatt SD, Friend PJ, et al. Prope tolerance with induction using campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Nippon Geka Gakkai Zasshi 2000; 101: 301-306.
6. Knechtle SJ, Pirsch JD, Fechner H, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study. Am J Transplant 2003; 3: 722-730. (Pubitemid 36745245)
7. Garcia M, Weppler D, Mittal N, et al. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation. Transplant Proc 2004; 36: 323-324. (Pubitemid 38407182)
8. Kandaswamy R, Gruessner R, Gruessner A, et al. Calcineruin inhibitor (CI) and steroid-free immunosuppression (ImmSx) for pancreas (Px) and px-kidney (KD) recipients using campath for both induction and maintenance (Maint.). Am J Transplant 2004; 4: 536.
9. Pascual J, Bloom D, Torrealba J, et al. Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: Clinical outcomes and effect on T-regulatory cells. Am J Transplant 2008; 8: 1529-1536. (Pubitemid 351989487)
10. Tan HP, Donaldson J, Basu A, et al. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up. Am J Transplant 2009; 9: 355-366.
11. Newell KA, Cendales LC, Kirk AD,. Finding the right job for the tool: Alemtuzumab and its role in renal transplantation. Am J Transplant 2008; 8: 1363-1364. (Pubitemid 351989511)
12. Pitman RS, Blumberg RS,. First line of defense: The role of the intestinal epithelium as an active component of the mucosal immune system. J Gastroenterol 2000; 35: 805-814.
13. Beagley KW, Husband AJ,. Intraepithelial lymphocytes: Origins, distribution, and function. Crit Rev Immunol 1998; 18: 237-254. (Pubitemid 128670069)
14. + T cells and commensal microbiota. J Immunol 2008; 180: 5843-5852.
15. Macpherson AJ, Harris NL,. Interactions between commensal intestinal bacteria and the immune system. Nature Rev Immunol 2004; 4: 478-485. (Pubitemid 38745559)
16. Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-bacterial mutualism in the human intestine. Science 2005; 307: 1915-1920. (Pubitemid 40404694)
17. Duan JY, Kasper DL,. Regulation of T cells by gut commensal microbiota. Curr Opin Rheumatol 2011; 23: 372-376.
18. Round JL, Mazmanian SK,. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009; 9: 313-323.
19. Ismail AS, Behrendt CL, Hooper LV,. Reciprocal interactions between commensal bacteria and γδ intraepithelial lymphocytes during mucosal injury. J Immunol 2009; 182: 3047-3054.
20. van der Windt DJ, Smetanka C, Macedo C, et al. Investigation of lymphocyte depletion and repopulation using alemtuzumab (Campath-1H) in cynomolgus monkeys. Am J Transplant 2010; 10: 773-783.
21. Guy-Grand D, Griscelli C, Vassali P,. The mouse gut T lymphocyte, a novel type of T cell: Nature, origin and traffic in mice in normal and graft versus-host conditions. J Exp Med 1978; 148: 1661.
22. Lefrancois L., Carbohydrate differentiation antigens of murine T cells: Expression on intestinal lymphocytes and intestinal epithelium. J Immunol 1987; 138: 3375-3384. (Pubitemid 17071920)
23. Vanhoutte T, Preter VD, Brandt ED, et al. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of Lactulose and Saccharomyces boulardii. Appl Environ Microbiol 2006; 72: 5990-5997. (Pubitemid 44414627)
24. Li Q, Zhang Q, Wang C, et al. Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant. PLoSONE 2011; 6: e20460.
25. Bercik P, Denou E, Collins J, et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011; 141: 599-609.
26. Smith PM, Garrett WS,. The gut microbiota and mucosal T cells. Front Microbiol 2011; 2: 1-6.
27. Leea YK, Menezesa JS, Umesakib Y, et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 2011; 108: 4615-4622.
28. Hale G,. CD52 (CAMPATH1). J Biol Regul Homeost Agents 2002; 15: 386-391.
29. Knechtle SJ, Burlingham WJ,. Metastable tolerance in nonhuman primates and humans. Transplantation 2004; 77: 936-939. (Pubitemid 38436839)
30. Cendales LC, Xu H, Bacher J, et al. Composite tissue allotransplantation: Development of a preclinical model in nonhuman primates. Transplantation 2005; 80: 1447-1454. (Pubitemid 41803628)
31. Tseng YL, Sachs DH, Cooper DK,. Porcine hematopoietic progenitor cell transplantation in nonhuman primates: A review of progress. Transplantation 2005; 79: 1-9. (Pubitemid 40139992)
32. Bibiloni R,. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-1546. (Pubitemid 41032360)
33. Reid G,. The scientific basis for probiotic strains of Lactobacillus. Appl Environ Microbiol 1999; 65: 3763-3766.
34. Vaughan EE, Mollet B, deVos WM,. Functionality of probiotics and intestinal lactobacilli: Light in the intestinal tract tunnel. Curr Opin Biotechnol 1999; 58: 505-510. (Pubitemid 29457279)
35. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004; 127: 412-421. (Pubitemid 39091889)
36. Martin HM, Campbell BJ, Hart CA, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004; 127: 80-93. (Pubitemid 38962277)
37. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002; 122: 44-54. (Pubitemid 34049193)
38. Rausch P, Rehman A, Künzel S, et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci USA 2011; 108: 19030-19035.
39. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004; 5: 104-112. (Pubitemid 38081475)
40. + T-cell receptor-bearing intestinal intraepithelial lymphocytes after microbial colonization in germ-free mice and its independence from thymus. Immunology 1993; 79: 32-37. (Pubitemid 23151190)
41. Ismail AS,., Severson KM, Vaishnava S, et al. γδ intraepithelial lymphocytes are essential mediators of host-microbial homeostasis at the intestinal mucosal surface. Proc Natl Acad Sci USA 2011; 108: 8743-8748.